P
US11078477B2ActiveUtilityPatentIndex 68

Automated isolation and chemical reaction(s) of nucleic acids

Assignee: BIOCHAIN INST INCPriority: Oct 17, 2014Filed: Oct 24, 2019Granted: Aug 3, 2021
Est. expiryOct 17, 2034(~8.3 yrs left)· nominal 20-yr term from priority
Inventors:HAN XIAOLIANGWANG JAMES JIANMINGLU TONG
C12Q 1/6806B01L 2300/0858G01N 2035/00564C12N 15/1013B01L 3/50851G01N 35/0098G01N 1/10C12Q 2523/125C12Q 2547/101
68
PatentIndex Score
2
Cited by
10
References
8
Claims

Abstract

The present teachings relate to methods, kits and devices for performing automated sequential nucleic acid isolation and conversion/purification in a single closed system. In various embodiments, the present teaching enable a user to (i) load a device with test samples, reagents and consumables; (ii) select or program the device for the desired nucleic acid isolation and subsequent chemical treatment and/or conversion reaction(s) without further user intervention; and recovering the isolated and treated and/or converted nucleic acid at the conclusion of the program once the device is activated.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
       1. A method for performing sequential nucleic acid isolation and conversion/purification reaction(s) in a closed automated device which includes:
 (A) a plurality of reaction reservoirs; 
 (B) a heating unit configured to heat the plurality of reaction reservoirs; 
 (C) a magnet configured to be elevated and lowered relative to the reaction reservoirs; 
 the method comprising: 
 a. contacting the nucleic acid-containing sample with an extraction reagent in a first reservoir of the plurality of the reaction chambers to thereby extract the nucleic acid from the sample; 
 b. binding the extracted nucleic acid with a first plurality of magnetic beads in the first reservoir; 
 c. while holding the magnetic beads down by elevating the magnet relative to the first plurality of magnetic beads, removing liquid supernatant formed in the first reservoir; 
 d. eluting the bound extracted nucleic acid from the first plurality of magnetic beads using a first elution buffer while subjecting the first reservoir to a first elevated temperature by the heating unit for a first predetermined duration of time to thereby obtain an isolated nucleic acid eluent; 
 e. while holding the magnetic beads down by elevating the magnet relative to the first plurality of magnetic beads, transferring the isolated nucleic acid eluent to a second reservoir of the plurality of reaction reservoirs, the second reaction reservoir containing a conversion reagent; 
 f. reacting said isolated nucleic acid with the conversion reagent in the second reservoir while subjecting the second reservoir to a second elevated temperature by the heating unit for a second predetermined duration of time, to thereby obtain a modified nucleic acid; 
 g. binding the modified nucleic acid with a second plurality of magnetic beads; 
 h. while holding the magnetic beads down by elevating the magnet relative to the second plurality of magnetic beads, removing liquid supernatant formed; 
 j. eluting the bound modified nucleic acid from the second plurality of magnetic beads using a second elution buffer or a second series of elution buffers to thereby obtain a purified modified nucleic acid eluent. 
 
     
     
       2. The method of  claim 1 , wherein said conversion is methylation. 
     
     
       3. The method of  claim 2 , wherein the methylation comprises bisulfite conversion. 
     
     
       4. The method of  claim 3 , wherein the bisulfite conversion is a deamination of cytosine into uracil of said isolated nucleic acid. 
     
     
       5. The method of  claim 3 , wherein the conversion reagent comprises bisulfite. 
     
     
       6. The method of  claim 3 , further comprising a step of desulfonation. 
     
     
       7. The method of  claim 1 , wherein the sample is selected from the group consisting of whole blood, plasma, serum, buffy coat, saliva, cheek swab, sputum, stool, urine, cerebral spinal fluid, a cell, a tissue and a formalin fixed paraffin embedded (FFPE) sample. 
     
     
       8. The method of  claim 1 , wherein the nucleic acid is DNA, RNA, cDNA or a combination thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.